Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
Condition: Triple Negative Breast Cancer Interventions: Drug: Carboplatin; Drug: Paclitaxel; Drug: Doxorubicin; Drug: Cyclophosphamide Sponsor: University of Illinois at Chicago Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials